IE45072B1 - Synthesis of 6-(d-2-phenyl-2-(4-pyridyl-formimidoylaminoacetamido)-acetamido)penicillanic acid - Google Patents
Synthesis of 6-(d-2-phenyl-2-(4-pyridyl-formimidoylaminoacetamido)-acetamido)penicillanic acidInfo
- Publication number
- IE45072B1 IE45072B1 IE1137/77A IE113777A IE45072B1 IE 45072 B1 IE45072 B1 IE 45072B1 IE 1137/77 A IE1137/77 A IE 1137/77A IE 113777 A IE113777 A IE 113777A IE 45072 B1 IE45072 B1 IE 45072B1
- Authority
- IE
- Ireland
- Prior art keywords
- phenyl
- reaction
- compound
- carbon atoms
- dimethylformamide
- Prior art date
Links
- RBKMMJSQKNKNEV-RITPCOANSA-N penicillanic acid Chemical compound OC(=O)[C@H]1C(C)(C)S[C@@H]2CC(=O)N21 RBKMMJSQKNKNEV-RITPCOANSA-N 0.000 title abstract description 27
- 230000015572 biosynthetic process Effects 0.000 title description 8
- 238000003786 synthesis reaction Methods 0.000 title description 5
- 238000000034 method Methods 0.000 claims abstract description 70
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 claims abstract description 52
- 230000008569 process Effects 0.000 claims abstract description 43
- NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 claims abstract description 40
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 177
- 238000006243 chemical reaction Methods 0.000 claims description 65
- -1 chloro, phenoxy, 4-chlorophenoxy, 4-nitrophenoxy phenylthio, 4-chlorophenylthio, 4-nitrophenylthio, 2-pyridylthio Chemical group 0.000 claims description 49
- 230000000903 blocking effect Effects 0.000 claims description 45
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 34
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 26
- 125000004432 carbon atom Chemical group C* 0.000 claims description 25
- 229910052739 hydrogen Inorganic materials 0.000 claims description 23
- 239000001257 hydrogen Substances 0.000 claims description 23
- 150000001875 compounds Chemical class 0.000 claims description 20
- 239000012442 inert solvent Substances 0.000 claims description 17
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 11
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 11
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical group C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 11
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 10
- 150000002431 hydrogen Chemical class 0.000 claims description 9
- 230000007062 hydrolysis Effects 0.000 claims description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims description 8
- 125000001246 bromo group Chemical group Br* 0.000 claims description 7
- 125000002346 iodo group Chemical group I* 0.000 claims description 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 7
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- OALPPYUMFWGHEK-UHFFFAOYSA-M potassium;benzenethiolate Chemical compound [K+].[S-]C1=CC=CC=C1 OALPPYUMFWGHEK-UHFFFAOYSA-M 0.000 claims description 4
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 3
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 235000009518 sodium iodide Nutrition 0.000 claims description 2
- LOTBYPQQWICYBB-UHFFFAOYSA-N methyl n-hexyl-n-[2-(hexylamino)ethyl]carbamate Chemical compound CCCCCCNCCN(C(=O)OC)CCCCCC LOTBYPQQWICYBB-UHFFFAOYSA-N 0.000 claims 2
- 238000005903 acid hydrolysis reaction Methods 0.000 claims 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 abstract description 29
- 238000005917 acylation reaction Methods 0.000 abstract description 24
- 230000010933 acylation Effects 0.000 abstract description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 87
- 239000000243 solution Substances 0.000 description 82
- 239000000047 product Substances 0.000 description 52
- 238000003756 stirring Methods 0.000 description 51
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 42
- 239000011541 reaction mixture Substances 0.000 description 34
- 239000002253 acid Substances 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 239000002904 solvent Substances 0.000 description 26
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 25
- 150000008064 anhydrides Chemical class 0.000 description 21
- 239000000203 mixture Substances 0.000 description 21
- FXYHMGFKNCQJTA-CQSZACIVSA-N (2R)-2-[[2-[[amino(pyridin-4-yl)methylidene]amino]acetyl]amino]-2-phenylacetic acid Chemical compound N1=CC=C(C=C1)C(=N)NCC(=O)N[C@H](C1=CC=CC=C1)C(=O)O FXYHMGFKNCQJTA-CQSZACIVSA-N 0.000 description 20
- 150000002148 esters Chemical class 0.000 description 19
- 239000000376 reactant Substances 0.000 description 18
- 239000000543 intermediate Substances 0.000 description 14
- 229940086542 triethylamine Drugs 0.000 description 14
- 230000035484 reaction time Effects 0.000 description 13
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
- 229930182555 Penicillin Natural products 0.000 description 7
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 7
- 239000002002 slurry Substances 0.000 description 7
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 6
- AGKAAGQPLPDBPL-QGZVFWFLSA-N [(2R)-2-[[2-[[amino(pyridin-4-yl)methylidene]amino]acetyl]amino]-2-phenylacetyl] 2,2-dimethylpropanoate Chemical compound C(C(C)(C)C)(=O)OC([C@H](NC(CNC(=N)C1=CC=NC=C1)=O)C1=CC=CC=C1)=O AGKAAGQPLPDBPL-QGZVFWFLSA-N 0.000 description 6
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical compound [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 6
- 150000001718 carbodiimides Chemical class 0.000 description 5
- 229940049954 penicillin Drugs 0.000 description 5
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 4
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- NBAKGIGLXAETCI-GOSISDBHSA-N butoxycarbonyl (2R)-2-[[2-[[amino(pyridin-4-yl)methylidene]amino]acetyl]amino]-2-phenylacetate Chemical compound C(CCC)OC(=O)OC([C@H](NC(CNC(=N)C1=CC=NC=C1)=O)C1=CC=CC=C1)=O NBAKGIGLXAETCI-GOSISDBHSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- VLYYHSYACZVSDA-MRXNPFEDSA-N ethoxycarbonyl (2R)-2-[[2-[[amino(pyridin-4-yl)methylidene]amino]acetyl]amino]-2-phenylacetate Chemical compound C(C)OC(=O)OC([C@H](NC(CNC(=N)C1=CC=NC=C1)=O)C1=CC=CC=C1)=O VLYYHSYACZVSDA-MRXNPFEDSA-N 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 3
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 3
- PGZVFRAEAAXREB-UHFFFAOYSA-N 2,2-dimethylpropanoyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC(=O)C(C)(C)C PGZVFRAEAAXREB-UHFFFAOYSA-N 0.000 description 3
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 238000005868 electrolysis reaction Methods 0.000 description 3
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 150000002960 penicillins Chemical class 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical class C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Natural products P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- VGGRCVDNFAQIKO-UHFFFAOYSA-N formic anhydride Chemical compound O=COC=O VGGRCVDNFAQIKO-UHFFFAOYSA-N 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 2
- 229940006461 iodide ion Drugs 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- SJHPCNCNNSSLPL-CSKARUKUSA-N (4e)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical class O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 description 1
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
- VTWKXBJHBHYJBI-VURMDHGXSA-N (nz)-n-benzylidenehydroxylamine Chemical compound O\N=C/C1=CC=CC=C1 VTWKXBJHBHYJBI-VURMDHGXSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- CTTJWXVQRJUJQW-UHFFFAOYSA-N 2,2-dioctyl-3-sulfobutanedioic acid Chemical compound CCCCCCCCC(C(O)=O)(C(C(O)=O)S(O)(=O)=O)CCCCCCCC CTTJWXVQRJUJQW-UHFFFAOYSA-N 0.000 description 1
- RFONJRMUUALMBA-UHFFFAOYSA-N 2-methanidylpropane Chemical compound CC(C)[CH2-] RFONJRMUUALMBA-UHFFFAOYSA-N 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- 101100096184 Alternaria solani sol5 gene Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 244000097654 Cudrania tricuspidata Species 0.000 description 1
- ZGUNAGUHMKGQNY-SSDOTTSWSA-N D-alpha-phenylglycine Chemical compound OC(=O)[C@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-SSDOTTSWSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- XAKBSHICSHRJCL-UHFFFAOYSA-N [CH2]C(=O)C1=CC=CC=C1 Chemical group [CH2]C(=O)C1=CC=CC=C1 XAKBSHICSHRJCL-UHFFFAOYSA-N 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- NRDQFWXVTPZZAZ-UHFFFAOYSA-N butyl carbonochloridate Chemical class CCCCOC(Cl)=O NRDQFWXVTPZZAZ-UHFFFAOYSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- NNPCWHQMEPPTJV-UHFFFAOYSA-N chloro(dimethoxy)phosphane Chemical compound COP(Cl)OC NNPCWHQMEPPTJV-UHFFFAOYSA-N 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 1
- 229960000878 docusate sodium Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- BXLJKQINBHOPFD-OAHLLOKOSA-N methoxycarbonyl (2R)-2-[[2-[[amino(pyridin-4-yl)methylidene]amino]acetyl]amino]-2-phenylacetate Chemical compound COC(=O)OC([C@H](NC(CNC(=N)C1=CC=NC=C1)=O)C1=CC=CC=C1)=O BXLJKQINBHOPFD-OAHLLOKOSA-N 0.000 description 1
- NJHSZWGAZDIXPZ-UHFFFAOYSA-N methyl pyridine-4-carboximidate Chemical compound COC(=N)C1=CC=NC=C1 NJHSZWGAZDIXPZ-UHFFFAOYSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- PJGSXYOJTGTZAV-UHFFFAOYSA-N pinacolone Chemical compound CC(=O)C(C)(C)C PJGSXYOJTGTZAV-UHFFFAOYSA-N 0.000 description 1
- 230000000063 preceeding effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- NLZATSTYDPCWOW-QGZVFWFLSA-N propan-2-yloxycarbonyl (2R)-2-[[2-[[amino(pyridin-4-yl)methylidene]amino]acetyl]amino]-2-phenylacetate Chemical compound C(C)(C)OC(=O)OC([C@H](NC(CNC(=N)C1=CC=NC=C1)=O)C1=CC=CC=C1)=O NLZATSTYDPCWOW-QGZVFWFLSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- URCQMYWDYIBZBV-UHFFFAOYSA-N tri(butan-2-yl)tin Chemical compound CCC(C)[Sn](C(C)CC)C(C)CC URCQMYWDYIBZBV-UHFFFAOYSA-N 0.000 description 1
- PIILXFBHQILWPS-UHFFFAOYSA-N tributyltin Chemical compound CCCC[Sn](CCCC)CCCC PIILXFBHQILWPS-UHFFFAOYSA-N 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- CPRPKIMXLHBUGA-UHFFFAOYSA-N triethyltin Chemical compound CC[Sn](CC)CC CPRPKIMXLHBUGA-UHFFFAOYSA-N 0.000 description 1
- NSPWVJAKNXJHEP-UHFFFAOYSA-N tripropyltin Chemical compound CCC[Sn](CCC)CCC NSPWVJAKNXJHEP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2224—Compounds having one or more tin-oxygen linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65611—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Processes for the preparation of 6-[D-2-phenyl-2-(4-pyridylformimidoylaminoacetamido)acetamido]penicill anic acid via acylation of 6-aminopenicillanic acid and derivatives thereof.
Description
Methods used to synthesise penicillins vary widely depending on the availability of starting reagents and the structure of the final product. It has now been discovered that 6-Q)-2-phenyl-2-(4-pyridylfonnimidoylaminoacetamido)acetamidoj penicillanic acid, a useful antibacterial agent, can be conveniently prepared by coupling 4pyridylformimidoylglycyl-D-phenylglyeine with 6-aminopenicillanic acid and derivatives thereof.
U.S. Patent 3,951,952 claims the product of the present invention and discloses its preparation by acylation of D-a-aminobenzylpenicillin with 4-pyridylformimidoylaminacetic acid as the acid chloride or activated ester and through the reaction of methyl 4-pyridylformimidate and 6-QD-2phenyl-2-(aminoacetamido)acetamido]penicillanic acid.
ΰο7·
It has now been found that the penicillin of the formula:
can he synthesized by contacting a 4-pyridylformimidoylglycyl-D-phenylglycine compound of the formula:
G-NHCHjCONHCHC-X
NH wherein X is chloro, phenoxy, 4-chlorophenoxy, 4-nitrophenoxy, phenylthio, 4chlorophenyIthio, 4-nitrophenylthio, 2-pyridylthio, N-phthalimidoxy, N-sucJinimiQoxyifc-benzotriazoloxy, -O-C(“NR')NHR wherein R* and R are each cyclo·
II hexyl or N-morpholinoethyl, or R-C-O- wherein R is selected from alkoxy having from one to four carbon atoms and t-butyl, with a 6ld aminopenicillanic acid of the formula:· ν’
Ζ wherein Ζ is hydrogen or a blocking moiety preferably selected from : .
XS1.
a) -p wherein R. and.' R, are each selected from _ Xr2 alkyl having one to three carbon atoms, alkoxy having one to three carbon atoms and phenyl;
b) 3,5-di-t-butyl-4-hydroxybenzyl;
. c)
II
-CH2-Y wherein Y is selected from “CR^ wherein R-g is selected from phenyl and alkyl having cne to three carbon atoms, -CN and carboalkoxy having two to four carbon atoms;
d) -N=CHR^ wherein R4 is selected from phenyl- and alkyl having one to three carbon atoms;
e) Sn(Rg)2 wherein Rg is alkyl having one to four carbon atoms;
f) CRgR^Rg wherein Rg and R? are each selected from hydrogen, phenyl and methyl and Rg is selected from phenyl, 4-methoxyphenyl, 4-nitrophenyl and methyl, provided that when Rg and R? are each methyl, Rg is also methyl;
g) -CH2CRgR10R1^ wherein Rg is selected from bromo, chloro and iodo and R^Q and R-q are each selected from hydrogen, bromo, chloro and iodo; and
h) Si(CH2)2R^2 wherein R^2 is selected from methyl and 6-aminopenicillanoyloxy, in a reaction inert solvent at a pH of 3.5-8 ahd reaction temperature of 0 to -15°C., followed by removal of the blocking moiety, Z.
- 4 4S072
A preferred feature of the present invention is the acylation of the· aforementioned 6-aminopenicillariic acid wherein Z is as defined,with 4-pyridylformimidoylglycyl-D-phenylglycine of the aforementioned formula wherein X is
If
R-C-O- wherein R is alkoxy having from one to four carbon atoms.
Si A second1 process leading to the penicillin of the formula:
comprises contacting a 4-pyridylformimidoylglycyl-D-phenylglycine compound of the formula:
NH c-nhch2conhchcox wherein X is chloro, phenoxy, 4-chlorophenoxy, 4-nitrophenoxy, phenylthio, 4chlorophenylthio, 4-nitrophenylthio, 2-pyridylthio, N-phthalimidoxy, N-suc10; cinimidoxy, 1-benzotriazoloxy, -O-C(»NR')NHR wherein R' and R are each cyclo-, tl hexyl or N-morpholinoethyl, or R-C-O- wherein R is alkoxy haying one to four carbon atoms and t-butyl, with a 6aminopenicillanie acid derivative of the formula:
- 5 Qrl*
in a reaction-inert solvent, pH of 3.3-8 and reaction temperature of
-10 to -5°C., followed by aqueous hydrolysis of the saccharimide group at a pH of 8-8.5. A preferred feature of this second process invention comprises the acylation of the aforementioned 6-aminopenicillanic acid derivative with a.4pyridylformimidoylglycyJ-D-phenylglycine compound of the aforementioned form/ . 0 ula wherein X is R-C-0- wherein R is alkoxy having from one to four carbon atoms.
Also’ considered within the scope of the present invention are the intermediate blocked derivatives of 6-[D-2-phenyl-2(4-pyridyl£ormifliidoylamino icetamido)acetamido]penicillanic acid compounds wherein Z is as defined, but Other than hydrogen.
Although acylation reactions of 6-aminopenictllanic acid are quite well known, it Is particularly surprising that under the reaction conditions of the instantly claimed processes, that there is no appreciable reaction of the derivatized 4-pyridylformiaidoylglycy1-D-phenylglycine with the more basic amidine portion of the side chain reactant.
In addition, there appears to be no racemization of the D-phenylglycine portion of the reactant side chain via intramolecular formation of an
2C oxazolone derivative.
As one skilled in the art can readily appreciate, the u-carbon atom oc the penicillin side chain to which the 4-pyridylformimidoylaminoacetamido moiety is attached is an asymmetric carbon atom allowing for the existence of two optically active isomers, the D- and L-diastereoisomers, as well as the racemate, DL form. In accord with previous findings concerning the activity of such penicillins possessing asymmetric a-carbon atoms, the compound of th present invention possessing the D-configuration is more active than that of the L-configuration and is the configuration to which the present applicatio is restricted.
. Further, it is noteworthy to mention while considering asymmetric centers, that there are several in the 6-aminopenicillanic acid nucleus, the basic building block from which the compounds of the present invention are derived. These potential additional isomers are not significant in this instance since the 6-aminopenicillanic acid employed leading to the product of this process invention is that which is produced by fermentation and is consistently of one configuration.
- 7 The first process reaction of the present invention is depicted in the following scheme:
NH
wherein X and Z are as previously defined.
- 8 In general, the acylation is carried put in a reaction-inert solvent,· said solvent being one which appreciably solubilizes the reactants without reacting to any great extent with either the reactants or the products under the reaction conditions. It is preferred that these solvents be highly polar, · aprotic solvents which are miscible with water and will not freeze or solidifyι at temperatures which represent the low end of the reaction temperature range of the claimed reaction process. Such solvents or mixtures thereof include 1aethyl-2-pyrrolidone, dimethylformamide, dimethylacetamide, dimethylsulfoxide and hexamethylphosphoramide. The preferred solvents are 1-methy1-2-pyrrolidorU and dimethylformamide.
The molar ratio of reactants is not a critical factor in the claimed . ι reaction process. The use of a slight excess of the 6-aminopenicillanic acid derivative, up to as much as ten percent, aids in the completion of the reactants and offers no serious problem in isolating the desired product in puri151 fled form.
Reaction time, too, is not critical, and ls inherently dependent on j concentration, reaction temperature and reactivity of the starting reagents. ( 'i Under the reaction-temperature conditions of about 0 to -15°C. the reaction is usually complete in 30 minutes to 3 hours.
I !
' The preferred reaction temperatures are those which allow the reaction to proceed at a practical rate without resulting in thermal degradation of the starting reagents or products of said process. Accordingly, temperatures of 0 to -15’C. are operable.
The order of the addition of the reactants is not critical. Because I
^ of the labile nature of the various derivatives of 4-pyridylformimidoylglycylD-phenylglycine, it is preferred that these reactants not be isolated.
Consequently, it is preferred that the appropriate derivative be prepared in situ from the corresponding 4-pyridylformimidoylglycyl-D-phenylglycine. It is further preferred that the requisite derivative in an appropriate solvent of the aforementioned description be added to 6-aminopenicillanic acid derivative
51' in an appropriate solvent or mixture of said solvents.
As previously mentioned, the claimed process is conducted at a pH of 3.5-8. This is most conveniently carried out by employing the appropriate » 4-pyridylformimidoylglycyl-D-phenylglycine derivative as some general acid addition salt. The preferred salts include the sulfate salt, £-toluenesulfonic acid salt, the hydrobromide salt, the phosphate salt and the hydrochloride salt.
The conversion of the 4-pyridylfonnimidcylglycyl-D-phenylglycine to the appropriate detivate suitable for acylation of the requisite 6-aminopenicillanic acid of the previously mentioned formula is carried out in a manner well-known to one skilled in the art. θ
II
In preparing those starting reagents wherein X is R-C-O- and R is alkoxy or t-butyl, 4-pyridylformimidoylglycyl-D-phenylglycine is contacted with
II about an equimolar amount of the appropriate acid chloride, R-C-Cl, wherein R is as previously defined. The solvents suitable for the preparation of the intermediate mixed anhydrides are those which are also useful in the claimed processes. Reaction temperatures of about -15ό0. are preferred, with a corresponding reaction time of 15-20 minutes. The preferred mixed anhydrides for the acylation of the 6-aminopenicillanic acid and derivatives thereof are those wherein R is ethoxy.
In synthesizing the acylating reagent wherein X is chloro, 4-pyridyl£ormimidoylglycyl-D-phenylglyeine is reacted with thionyl chloride in one or more of the solvents previously described as suitable for the claimed processes: The reaction temperatures of -15 to -20’ are preferred, with a corresponding
Si reaction time of 45-60 minutes.
Preparation of those acylating reagents wherein X is -O-C(”NR')NHR where R' and R are each cyclohexyl or N-morpholinoethyl is carried out by contacting 4-pyridylformimidoylglycyl-D-phenylglyc.ine with the appropriate carbodiimide, R'-N»C»N-R. Approximately equimolar amount of reactants are
1Q| employed, said reaction being conducted in one or more of the solvents operable in the claimed processes. The reagent is generally formed at ambient temperatures requiring only a few minutes reaction time. The solution of the acylati-i- agent is subsequently cooled to 0 to -15°C. for the reaction with the requisite 6-aminopenicillanic acid or derivative thereof.
lit For the synthesis of those acylating agents wherein X is phenoxy, 4chlorophenoxy, 4-nitrophenoxy, phenylthio, 4-chloropbenylthio, 4-nltrophenylthio, 2-pyridylthio, N-phthalimidoxy, N-succinimidoxy or 1-benzotriazoloxy, it is preferred that they be prepared through either the mixed anhydride or the intermediates wherein X is -O-C(“NR')NHR both of whose preparation has pre2^ vlously been discussed. In practice, after the mixed anhydride or isourea has been prepared In situ, the appropriate N-hydroxy compound, phenol or thiol is added in about equimolar amounts, resulting in the formation of the corresponding activated ester. Alternatively, all three reactants, 4-pyridylformimidoylglycyl-D-phenylglycine, the carbodiimide and the N-hydroxy compound,
- 11 <12072 ’j phenol or thiol, can be added all at the same time. The solvents preferred for.
the preparation of the activated ester acylating agents are the same suited to the processes of the present invention. Ambient temperatures are preferred fori 1
J the formation of the acylating compound, with a reaction time of 15-20 minutes.5.. The aforementioned acylating agents can be used to acylate 6-aminopenicillanic acid directly (wherein Z is hydrogen) or, alternatively,a derivative of 6-aminopenicillanic acid wherein Z is other than hydrogen as previously d defined. These other derivatized forms of ό-aminopenicillanic acid are well ii known to those skilled >in the art and are relatively easy to prepare, Fol* . . · ' . * · lowing the acylation of these'derivatives, the blocking group, Z, is subsequently removed in a manner dictated by the nature of said Z group. “.
j The first of these blocking groups is the phosphine ester, the preparation of which is taught in W. German application 2,218,209. Of those definitions for K . and R. variables for the group -P^^l , methoxy is especially
- 2 K2 preferred. The preferred solvent is dimethylformamide and the preferred reaction' temperature for the acylation reaction employing this 6-aminopenicillanic acid derivative is 0°C. Removal of the blocking group is conveniently carried 1 out by additon of water.
A second blocking group is that wherein Z is 3,5-di-b-butyl-4-hydroxy20. benzyl, the preparation of this 6-aminopenicillanic acid derivative being taught
I in W. German application 2,033,493.- The preferred solvent for this acylation reaction is dimethyLformamide. The reaction temperature is -10’C. with a corresponding reaction time of 20-30 minutes. Following the acylation of the 6aminopenicillanic acid derivative, the blocking group is removed by aqueous
|J hydrolysis at pH 8.0.
- 12 The third type of blocking moiety suitable for 6-aminopenicillanic acid are those wherein Z is CH2-Y where Y is as previously defined. The preparation of these 6-aminopenicillanic acid derivatives is taught in Acta. Chem. Scand., 21, 2210 (1967). It is preferred that these derivatives he acylated in the preferred reaction-inert solvent of dimethylformamide at a reaction temperature of -10eC. for a reaction time of about 30 minutes. Removal of the blocking group is done by treatment with iodide ion, thiocyanate or mercaptan ion or an amine; the preferred removal is with potassium thicphenomide. The ti preferred Y for this blocking group is -C-R^ wherein R^ is phenyl.
1C The fourth type of blocking moiety is that wherein Z is -NaCHR^ wherein is as previously defined. The synthesis of these 6-aminopenicillaniC intermediates is taught in £. Chem. Soc., 1917 (1971c). Dimethylformamide is , the preferred solvent for the acylation of these derivatives, emrloying a ; reaction temperature of 0°C. and reaction time of 30-45 minutes. At the com151 pletion of the acylation reaction the blocking moiety can be removed by treatment with a nucleophile such as mercaptide, thiocyanate or iodide ion. The prer ferred removal is with sodium iodide. The preferred for this blocking moietjr is phenyl.
The fifth type of' blocking group employed in the claimed process is that where Z is Srt(R5)g, said 6-aminopenicillanic acid derivatives having been prepared according to the method as reported in Acta. Chem. Scand.. 22, 367 (1968). Acylation of these blocked 6-aminopenicillanic acid derivatives is preferably carried out in dimethylformamide as the reaction solvent, employing a reaction temperature of -5°C. and a corresponding reaction time of 30-45 minutes. The blocking group can be conveniently removed using a mercaptide or thiocyanate ion as the nucleophile; the preferred reagent for removal is potassium thiophenosd.de. The preferred Rg for this blocking moiety is n-butyl.
The sixth useful blocking group, Z, on the 6-aminopenicillanic acid reagent is -CRgR^Rg wherein Rg, R? and Rg are as previously defined. These derivatives are prepared by the method as taught in J. Med. Chem., 11, 929 (1968). Especially preferred in the process are those intermediates wherein Rg and Ry are each hydrogen and Rg is 2-methoxyphenyl. The acylation reaction is conveniently carried out in the preferred solvent, dimethylformamide, at a reaction temperature of -10°C. and reaction· time of 30-45 minutes. When the reaction is complete, the blocking moiety can be removed by hydrolysis with hydrofluoric acid or by catalytic hydrogenation using palladium on charcoal.
Both these latter methods of removal are preferred.
The seventh type of blocking group useful in the claimed process is that wherein 2 is -CHjCRgS^gR^ where Rg, R^q and R^ are as indicated. These 6-aainopefiicillSnic acid intermediates ate prepared by the procedure of West German Application 1,937,962. The preferred solvent for the acylation of thesei derivatives is dimethylformamide, the preferred reaction temperature being -5°c!. with a reaction time of 30-60 minutes. The blocking group, wherein the preferred
- 14 a £>0 7 2 definition of Rg, R^ and R^ are each chloro, is removed by electrolytic reduc· cion.
The eighth type of blocking moiety is that wherein Z is -SiCCHj^Rp wherein R^ is as previously indicated; the preferred R^ is CHy Acylation of
5j' these blocked 6-aminopenicillanic acid derivatives is conveniently carried out in dimethylformamide, with a reaction temperature of -10°C. and reaction time of 60-90 minutes. The blocking group is easily removed by simple water hydrolysis. Such blocked derivatives of 6-aminopenicillanic acid are prepared according to Che procedures in Ann., 673, 166(1964).
iQj As previously mentioned, the claimed process can also· be applied to the acylation of che unblocked 6-aminopenicillanic acid wherein Z is hydrogen. The preferred solvent for this ecylation is l-methyl-2-pyrrolidone and the reaction temperature should be maintained at about -10°C. Employing these cont ditions, the reaction time is about 15-20 minutes.
15jf In all the aforementioned acylation reactions the desired product,
6-[D-2-phenyl-2-(4-pyridylformimidoylaminoacetamido)acetamldo]penicillanic acidl, is conveniently isolated by the precipitation of the zwitterion with the addition of methanol to the reaction mixture after the blocking group has been removed. As one skilled in the art can readily appreciate, very low concentra2(j tion (g./ml.) of the product in the reaction mixture makes isolation by addition of a precipitating solvent very inefficient. Accordingly, it is preferred! that when a dilute solution of 1-27! of the product in the reaction mixture are employed, that the mixture be concentrated such that higher concentrations are ' obtained. In general, a concentration of the product in the reaction mixture
2^j of 10% or better result in excellent recovery by methanol precipitation. 0bi viously, when 2 is hydrogen no removal prior to isolation is necessary. Such precipitation of the product should be carried out as near as possible to its isoelectric point of pH 5.5. Depending on the pH of the solution after de- ; blocking, hydrochloric acid or aqueous sodium hydroxide solution can be added
3$ to adjust the pH to said isoelectric point.
I 4.a ο τ 3
A second process of the present invention, useful for the synthesis of 6-[Q-2-phenyl-2-(4-pyridylformimidoylhminoacetamido)AcetamidoJpenicillanic acid, is depicted in the following scheme:
NH
C=0
wherein X is as previously defined.
->
-16 - v - αΰογ3
The acylation is carried out, as indicated in the first process, in a. reaction-inert solvent, said solvent being one which appreciably solubilizes the reactants without reacting to any great extent with either the reactants or the products under the reaction conditions. Again, it is preferred that these sol5 vents be highly polar, aprotic solvents which are miscible with water and will ' not freeze or solidify at temperatures which represent the low end of the reaction temperature range of the claimed reaction process. Such solvents or mixtures thereof include l-methyl-2-pyrrolidone, dimethylformamide, dimethylacetamide, dimethylsulfoxide and hexamethylphosphoramide. The preferred solvent ioji is dimethylformamide.
The molar ratio of reactants is not a critical factor in the claimet reaction process. The use of a slight excess of the 6-aminopenicillanic acid saccharimide derivative, up to as much as ten percent, aids in the completion of the reactants and offers no serious problem in Isolating the desired product l
·! in purified form.
I
Reaction time, too, is not critical, and is inherently dependent on concentration, reaction temperature and reactivity of the starting reagents. Under the reaction-temperature conditions of about -10 to -5°C., the reaction is usually complete in 30-60 minutes.
2(J! The preferred reaction temperatures are those which allow the reaction to proceed at a practical rate without resulting in thermal degradation of the starting reagents or products of said process. Accordingly, temperatures of -10 to -5°C. are operable, with a preferred temperature of -5°C.
The order of the addition of the reactants is not critical. As
2^ previously discussed, because of the labile nature of the various derivatives of 4-pyridylformifflidoylglycyl-D-phenylglycine, it is preferred that these reactants not be isolated. Consequently, it is preferred that the requisite derivative be prepared in situ from 4-pyrldylformimidoylglycyl-D-phenylglycine;
ΰ Ο 7Ζ ·
In addition, it is preferred that the requisite derivative in an appropriate solvent of the aforementioned description be added to the 6-aminopenicillanic ι
i acid saccharimide derivative in an appropriate solvent or mixture of solvents.
Following the completion of the acylation reaction, the blocking ' saccharimide group is removed by adjusting the pH of the reaction mixture to [ ’ 8-8.5 with a suitable inorganic base and allowing the mixture to stir at room temperature for about 3-4 hours.
Isolatioti.of the desired product is achieved as in the first process 'by precipitation of the zwitterion at the isolated point of 5.5. Aqueous hydro
101! chloric acid is'used to lower the pH to this preferred pH.
The starting 6-aminopenicillanic acid saccharimide derivative is synthesized by the procedure of British Patent 1,281,952.
Also included Within the scope of the present invention as useful intermediates are the intermediate blocked derivatives of 6-[D-2-phenyl-2-(4lsfj pyridylformimidoylaminoacetamido)acetamido]penicilianic acid of the formulae:
wherein Z is as previously described, hut other than hydrogen»
- 18 Among these useful intermediates which are especially preferred are ;
those related to I where 2 is -PR^ and R2 where R^ and R, are each methoxy; Z o :
ιι I .‘.s 3,5-di-C.-butyl-4-hydroxybenzyl; Z is -CHjCRg where Rg is phenyl; Z is -N»CHR^ where R^ is phenyl; Z is Sn(Rj)g where R^ is n-butyl; Z is -CRgR^Rg where R& and
I
R? are each hydrogen and Rg is £-me thoxy benzyl; Z is -Cl^CRgR^R.^ wherein Rg, R^g and R^ are each chloro; and Z is -SiiCHj^Rj^ where R^ is CHg. Also preferred is the compound of formula II.
The penicillin described herein exhibits in vitro activity against a wide variety of micro-organisms, including both gram-positive and gram-negative,
1C bacteria. Its useful activity can readily be demonstrated by in Vitro tests l
against various organisms in a brain-heart infusion medium by the usual two- ί fold serial dilution technique. The in vitro activity of the herein described compound renders it useful for topical application in the form of ointments, creams and the like, or for sterilization purposes, e.g., sick-room utensils.
·? This penicillin is also an effective antibacterial agent in vivo in animals, including man, via the parenteral route of administration.
Obviously, the physician will ultimately determine the dosage which will be most suitable for a particular individual person, and it wiljvary with the age, weight and response of the particular patient as well as with the
2>)l nature and extent of the symptoms and the nature of the bacterial infection being treated.
Having full regard for the foregoing factors, it is considered that . an effective'daily parenteral dose of 25-100 mg./kg. per day, with a preferred) range of about 20-75 mg./kg. per day, will effectively alleviate the symptoms
2^i of the infection. These values are Illustrative, and there may, of course, be individual cases where higher or lower dose ranges are merited.
The following examples are provided solely for the purpose of illustration.
- 19 EXAMPLE 1
6- [p-2-Phenyl-2-(4-pyridylformimidoylaminoacetamido)acetamido] penicillanic acid pTo a solution of 10.32 g. of 4-pyridylformimidoylglycyl-D-phehylglycine in 125 ml. of dimethylformamide at -15°C. is added 3.56 g. of ethyl chloroformate, and the resulting solution, after stirring at -15°C. for 15 min., is cooled to -20°C.
To a suspension of 7.13 g. of 6-aminopenieillanie acid in 60 ml. of water neutralized to pH 7.8 with a dilute aqueous sodium hydroxide solution and cooled to 5°C. is added 40 ml. of dimethylformamide. The solution is then cooled to -10°C. and the solution of the dipeptide mixed anhydride is added slowly over a 5 min. period. Cooling is continued during the additon such that the temperature remains at -10 — 1°C. The reaction mixture is allowed to stir at -10°c. for an additional 15 min., and is then allowed to warm to room temperature. The clear solution is concentrated in vacuo at 35°C. to approximately 135 ml., and is diluted with 400 ml. of methanol. After stirring over night, the resulting precipitate is filtered, washed with methanol and dried, 12.97 g. (74% yield).
The product is indistinguishable via infrared and nuclear magnetic resonance spectroscopy from that prepared by the processes of U.S. #=3,951,952.
Similar results are obtained when methyl, i-propyl and n-butyl chloroformates are employed in place of ethyl chloroformate.
EXAMPLE 2.
To a solution of.1,25 g. of 4-pyridylformlmldoylglycyl-Dphenylglycine in 25 ml* of dry dimethylformamide cooled to -15pc. is added 485 mg. of pivaloylchloride. After allowing the reaotion mixture to stir for 15 min. at -10°C., 950 mg. of 6aminoperticillanic acid in 20 ml. of water adjusted to pH 7.8 and at a temperature of 5°c. is added to the dimethylformamide solution. The temperature,· which rose to 7°C. during the addition, was held at 0°C. for 15 min,and then allowed to warm to room temperature over a 30 min. period.
High-pressure-liquid-chromotography of an aliquot indicates a yield of 1.17 g. (58% yield) of the desired product, 6-[p-2-phenyl2-(4-pyridylformimidoylaminoacetamido)acetamido] penicillanic acid, identical with the product of Example 1.
EXAMPLE 3
A suspension of 2.16 g. of 6-aminopenicillanic acid in 40 ml. of methylene chloride is treated with 1.08 g. of triethylamine and allowed to stir at room temperature until a clear solution results. The solution is cooled co 0°C. and 1.28 g. of dimethoxychlorophosphine is added.
After stirring for 15 min. a solution of the mixed anhydride, formed by adding 1.18 g. of ethyl chloroformate to 3.12 g. of 4-pyridylformirnidoylglycyl-D-phenylglycine in 40 ml. of dimethylformamide cooled to -15°C., is added over a five minute period while the reaction temperature is maintained at 0 to -5°C. Stirring is continued for an additional 30 min. followed-by dilution of the reaction with 20 ml. of water. The hydrolyzed reaction mixture is stirred for 20 min. and the aqueous layer separated and treated with 200 ml. of methanol. The product, which cryscallizes from the aqueous-methano solution, is identical to that isolated in Example 1.
- 21 EXAMPLE 4
The.following pairs of mixed anhydrides and phosphine penicillanic acid esters prepared by the procedures of Examples 1 and 2, and 3, respectively provide the desired product, 6-[D-2-phenyL-2-(4-pyridylformiraidoylaminoace5 tamido)acetamido]penicillanic acid:
4-pyridylformiraidoylglycyl-D-phenylglycine methoxyformic anhydride and di-n-propyiphosphinyl 4-aminopenicillanate;
4-pyridylformimidoylglycyl-D-phenylglycine _i-propoxyformic anhydride and diphenylphosphinyl 4-aminopenicillanate;
4-pyridylformimidoylglycyl-D-phenylglycine n-butoxyformic anhydride and dimethoxyphosphinyl 4-aminopenicillanate;
4-ρyridylformimidoylglycyl-D-ph'l·nylglycine pivalic anhydride and dimethoxyphosphinyl 4-aminopenicillafiate;
4-pyridylformimidoylglycyl-D-phenylglycine ethoxyformic anhydride 15 and di-n-propylphosphinyl 4-aminopenicillanate; and
4-pyridylformimidoylglycyl-D-phenylglycine pivalic anhydride and diphenylphosphinyl 4-aminopenicillanate;
-,22 «2072
EXAMPLE 5
A. S-Pyridylformimidoylglycyl-D-phenylglycine ethoxyformic anhydride
Xn a manner similar to Example 4, a solution of 3.12 g. of 4-pyridylformimidoylglycyl-D-phenvlgiycine in 40 ml. of dimethylformamide cooled to -15°t.
is treated with 1.18 g. of ethyl chloroformate. After stirring for 15 min. ac -15“C. the solucion is further cooled, to -50’C.
B. 6-[D-2-Pheny1-2(4-pyridylformimldoylarninoacetamido)acetamidoJpenicillanic acid
A solution of 5 g. of 6-aminopenicillanic acid, 3',5'-di-e_-butyl*-4'10 hydroxybenzyl ester in 50 ml. of N-methyl-2-pyrrolidone at -10’C. is treated with a dimethylformamide solution of 4-pyridylforraimidoylglycyl-D-phenylgl'ycinej ethoxyformic anhydride (Example 5A). After stirring 20 min. at -10° to -15°C. che cooling bath is removed'and a solution of 1.82 g. of sodium 2-ethylhexanoatje . in 20 ml. of methanol is added. Stirring is continued for 3 hrs. at room tem15 perature followed by the addition of 200 ml. of methanol. The product, which crystallizes, is identical with that isolated from Example 1.
- 23 EXAMPLE ft
The following mixed anhydrides, when reacted with 6-aminopenicillanic; acid, 3',5'-di-c-butyl-4-hydroxybenzyl ester according to the procedure of Example 5B, provides the desired produce, 6-[D-2-phenyl-2-(i-pyridylformirai5 doylaminoaceeamido)acetamido]penicillanic acid:
• A-pyridylfortnimidoylglycyl-D-phenylglycine me thoxy formic anhydride;
i-pyridylformimidoylglycyl-D-phenylglycine i-propoxyforntic anhydride
4-pyridylf0rmiraidoyiglycyl-D-phenylglycine n-butoxyformie anhydride;
and
4-pyridylfarmimidoyiglycyl-D-phenylglycine pivalic anhydride.
EXAMPLE 7
To an ice-cooied suspension of 4.9 g. of 6-aminopenicillanic acid, phenacyl ester benzenesulfonic acid halt in 50 ml, of dimethylformamide is added 1,1 g. of triethylamine.' To the resulting solution, which is cooled to
-5* to -lO’C,, is added slowly the mixed anhydride as prepared in Example 5A.
Af ter-stirring in the cold for 30 min., the reaction mixture is diluted with 100 ml. of water and extracted with ethyl acetate. The organic extracts are combined, washed with water, dried over sodium sulfate and concentrated to dryness. The residue is dissolved in 40 ml. of dimethylformamide and treated with a solution of 1,2 g. of potassium thiophenoxide in 10 ml, of dimethylfor.maaide. After stirring at room temperature for one hour the pH of the solution is adjusted to 5.5 by the addition of 2N hydrochloric acid followed by che addition of 200 mi. of methanol. The desired product which slowly crystallizes from: the solution is identical in all respects to che 6-[b-2-phenyL·
2-(4-pyridyl£o,rmimidoylaainoacetamido)acetamidoIpenicillanic acid formed in previous examples.
- 24 EXAMPLE 8 αίϊο?2
6-[D-2-Pheny1-2-(4-pyridylformiraidoylarainoaeetamido)acetamido]penicillanic acid, identical with that prepared in preceeding examples, is synthesized by following the procedure of Example 7 employing the following pairs of reactants:
4-pyridylforntiaidovlglycyl-D-pheny lglycine me thoxy formic anhydride and 6-aminopenicillanic acid, acetonyl ester;
4-pyridylforaimidoylglycyl-D-phenylglycine .n-butoxyformic anhydride and 6-aminopenicillanic acid, cyanomethyl ester;
4-pyridylformimidoylglycyl-D-phenylglycine athoxyformic anhydride and 6-aminopenicillanic acid, methoxycarbomethyl ester;
4-pyridylformimidoylglycyl-D-phenylglycine pivalic anhydride and 4aminopenicillanic acid, phenacyl ester;
4-pyridylformimidoylglycyl-D-phenylglycine i-propoxyformic anhydride 15 and 4-aminopenicillanic acid, propionylmethyl ester;
4-pyridylformimidoylglycyl-D-phenylglycine ethoxyformic anhydride and 4-aminopenicillanic acid, i.-butyrylmethyl ester;
ι
4-pyridylformimidoylglycyl-D-phenylglycine pivalic anhydride and 4-aminopenicillanic acid, n-propoxycarbomethyl ester;
4-pyridylformimidoylglycyl-D-phenylglycine n-butoxyformic anhydride and 4-aminopenicillanic acid, cyanomethyl ester; and
4-pyridylformimidoylglycyl-D-phenylglycina pivalic anhydride and 4-aminopenicillanic acid, acetonyl ester.
EXAMPLE 9
A solution of 4.9 g. of 0-(6-aminopenicillanoyl)benzaldehyde oxime jytoluenesulfonic acid salt in 50 ml. of N-methyl-2-pyrrolidone cooled to 0*C. is treated with 1.1 g. of triethylamine and then 4-pyridyIfomimidoylglycyl5 D-phenylglycine ethoxyformic anhydride in 40 ml. of the same solvent prepared according co the procedures of Example 5A. After stirring in the cold for 30 min. the solution is warmed to room temperature and 1.5 g. of sodium iodide1 in 20 ml. of acetone is added. Stirring is continued for 3 hrs. followed by dilution of the solution with 200 ml- of methanol and adjustment of the pH
101 to 5.5 with 2N hydrochloric acid. The precipitated product, when filtered, is identical to 6-[D-2-phenyl-2-(4-pyridylfotmimidoylaminoaceeamido)acetamldo]i : penicillanic acid prepared in Example 1.
EXAMPLE 10
In a manner similar to Example 9, the following 6-aminopenicillanic 15 ) acid ester and anhydrides are reacted to give 6-(D-2-phenyl-2-(4-pyridylformimidoylaminoacecamido)acecamido]penicillanic acid, Identical to that preparedl in preceedlng examples:
- 26 <ίΰο7
tt
0- -o-c-och3 0- 0 ..()-C-OC4Hg 0- 0 -0-C-OC3H7 0- 0 -O-CC(CH3) CH3- 0 -O-C“OC2Hs ch3- 0 -o-cc(ch3).C2H5~ ό -OCC(CH3)3C2H5- 0 -O-C-OCHj n-C3H7- 0 -O-C-OCH3 n-C3H7- 0 ~)-C-0C,Ho 4 9 >c3h7- 0 ~>-C-OC,tl, J /
EXAMPLE 11
To a solution or 5.0 g. of tri-n-butyltin 6-aminopenicillinate in - 50 ml. of dimethylacetamide cooled to -5°C. is added a solution of 4-py'ridylformimidoylglycyl-D-phenylglycine ethoxyformic anhydride as prepared in 5 Example 5A. After stirring in the cold for 30 min., the reaction solution is allowed co warm to room temperature and is subsequently treated wich 1.62 g. of potassium.thiophenoxide. After stirring for 30 min. at room temperature, the solids are filtered and the filtrate diluted with 200 ml. of methanol.
The crystallized material, after filtration, provided the desired 6-[D-2-phenyir
.- 2-(4-pyridylformimidoylaminoacetamido)acetamido]penicillanic acid product, identical with that formed in Example 1.
EXAMPLE 12
Following the procedure of Example 11, and starting with indicated pairs of appropriate.reactants, 6-[D-2-phenyl-2-(4-pyridylformimidoylamino15 acetamido)acetamido]penicillanic acid, identical with that formed in Example 1. is prepared:
4-pyridyiformimidoylglycyl-D-phenylglycine ethoxyformic anhydride and trimethylcin 6-aminopenicillinate;
4-pyridylformimidoylglycyl-D-phenylglycine pivalic anhydride and 20 triethyltin 6-aminopeniciliinatej
4-pyridylformimidoylglycyl-D-phenylglycine methoxyformic anhydride and tri-jl-propylcin 6-aminopenicilHnate;
- 28 a· «y-y-— <ϊίϊ07;3
4-pyridylformimidoylglycyl-D-phenylglycine n-butoxyformic anhydride and tri-L-butyltin 6-aminopenicillinate;
4-pyridylformimidoylglycyl-D-phenylgJvcine _i-propoxy formic anhydride and tri-L-propyltin 6-aminopenicillinate;
4-pyridylformimidoylglycyl-D-phenylglycine pivalic anhydride and tri-s-butyltin 6-aminopenicillinate; and
4-pyridylformimidoylglycyl-D-phenylglycine ethoxyformic anhydride and tri-£-propyltin 6-aminopenicillinate.
EXAMPLE 13
A solution of 4-pyridylformimidoylglycyl-D-phenylglycine ethoxyformicj anhydride, prepared according to the procedure of Example 5A, is added over a 5 min. period to a solution of 3.3 g. of 6-aminopenicillanic acid, £methoxybenzyl ester in.40 ml. of dimethylformamide cooled to -10“C. Stirring is continued in the cold for 30 min. followed by the addition of 200 ml. of
IS water. The pH is subsequently adjusted to 6.0 and the solution washed twice with methyl t-butyl ketone. The pH of the aqueous phase is then lowered to 2.0 and extracted (3x) with a 52 dioctyl sulfosuccinic acid in methyl i^butyl ketone. The organic phase is separated, washed with dilute hydrochloric acid and layered with water, the pH of which is adjusted to 6.0. The aqueous layer is separated and lyophylized to give the crude intermediate ^-methoxybenzyl ester of 6-[D-2-phenyl-2-(4-pyridylformimidoylaminoacetamido)acetamidojpenicillanic acid hydrochloride salt.
- 29 S ' ' .
α2073 . ;
The crude ester hydrochloride salt is added to 100 ml. of acetone containing 10 g. of anhydrous hydrogen fluoride and the mixture allowed to stir at 0°C. for one hour. Most of the solvent is removed at O’C. under reduced pressure and the residue dissolved in 25 ml. of water. The pH of the aqueous solution is raised to 5.5 with a 2ίί sodium hydroxide solution and created with decolorizing charcoal. The filtrate, is treated with 25 ml. of dimethylformamide and 200 ml. of methanol. The product which crystallizes is identical to 6-[D-2-phenyl-2-(4-pyridylformimidoylaminOacetamido)acetamido]penicillanic acid, the product of Example 1.
EXAMPLE 14
In a manner similar co Example 13, the following 6-aminopenicillanic acid ester and anhydrides are reacted to give 6-[D-2-pheny1-2-(4-pyridylformimidoylaminoacetamido)acetamido]penicillanic acid, identical to that prepared in. Example 1:
Hn.
^cx-NHCH2C0NHCH-C0i 'NH \ S CH
MX
CH, co2ii
S ο 7 2
X 0 II CH3- CH3- CH3- -O-C-OC,H. 2 3 0 II ch3- ch3- ch3- -O-CC(CH3>3 0 II Η- ch3- 4-CH3OC6H4- -0-C-OCH3 0 II Η- CH3- 4-CH,0C,H,~ 3 6 4 -O-C-OC3H7 0 II ch3- ch3- 4-CH3<)Cj.Hr -O-C-OC2H5 0 II ch3- CHj- 4-CH3OC6H4- -o-c-oc4h9 0 II Η- H-4-NO2C6H4 -O-C-OC,H5 0 tf Η-C6H5“C6H5 -O-C-OC2H5 0 tl Η-C6H5“ W -O-CC(CH3)3 0 If °6Η5-C6H5‘C6H5“ -O“CC(CH3)3 0 tfC6H5- WC6H5- -0-C-OCH3 0 IIC6H5” w 4-CH3OC6H4- -O-C-OC3H7 0 IIC6H5-CA 4-NO2C6H4- -O-CC(CH3)3 0 II Η- CH3- 4-NO2C6H4- -O-C-OC2H5 0 II Η- ch3- 4-N°2C6V -O-C-OCH3
EXAMPLE 15
A solution of 3.48 g. of 6-aminopenicillanic acid, S,3,3-crichloroethyl ester in 40 ml. or dimethylformamide cooled to -10°C. is treated dropwise over a 5 min. period with a dimethylformamide solution of 4-pyridylforI ’ mimidoylglycyl-D-phenylglycina ethoxyformic anhydride prepared according to the procedure of Example SA. After stirring for 30 min. at -5 to -10’C., the reaction mixture is diluted with 20 ml. of water and poured into the cathode side of a divided cell preparative electrolysis apparatus. The anode compartment is filled with 0.1M sodium chloride solution containing 1 g. of hydrazine hydrochloride. Plate graphite anode aqd cathode electrodes (2.5 x 4 cm) were introduced, and the cathode adjusted to -1.5 vc (vs. S.C.E.) using a Princeton Applied Electronics Model 373 potentiostat. Constant potential electrolysis is carried out'until che current has fallen co 52 of its original value. During this time period the pH of the cathode compartment is maintained at 5.5 and the interior temperature at 20°C. A total'of 650 milliamps is consumed during the electrolysis period of 3 hrs.
The contents of the cathode compartment is decanted and the solution treated with 200 ml. of'methahol. The solution, on standing, deposits a crystalline material identical with product from Example 1.
Similarly, reduction results were obtaihed by treating the crude trichlotoethyl ester.intermediate in solution with sufficient acid to provide a pH of 1.0, followed by addition of 1 g. of zinc dust at 0“C. fot 1 hr.
- 32 / α « Ο 7 3
EXAMPLE 16
Using Che electrolytic reduction procedure of Example 15, the following esters are employed as starting materials for the synthesis of 6-[D~2phenyl-2-(4-pyridyIformiaidoylaminoacetamido)acetamido]penicillanic acid:
22 ‘TO Cl H H I . H H Cl Cl H Cl Br H Br I H Cl Br Br Cl Cl Br Cl X H Cl Cl I Br Br H Br Br Br
EXAMPLE 17
The procedure of Example 13 is repeated. One gram of the intermediate
6-[D-2-phenyl-2-(4-pyridylformimidoylaminoacetamido)acetamidoJpenicillanic acid, jj-methoxybenzyl ester hydrochloride in 10 ml. of water and 20 ml. of dimethyls’ rormamide is treated with 2. g. of 102 palladium on charcoal and the resulting mixture shaken in a hydrogen atmosphere at atmospheric pressure. After the theoretical amount of hydrogen is absorbed, the spent catalyst is filtered and the filtrate adjusted to pH 5.5 and diluted with 100 ml. of methanol. After crystallization,there is obtained 6-[D-2-phenyl-2-(4-pyridylformimidoylamino1C1 acetamido)acetamido]penicillanic acid, identical with that prepared in Example
1.
In a similar manner, the intermediate ester products of Example 14 are hydrogenated co give the desired product, 6-[D-2-phenyl-2-(4~pyridyifotmimidoylaminoacetamido)acecamdio]penicillanic acid.
/ο·?*.
EXAMPLE 18
To 50 ml. of dimethylformamide in a dry round-bottom flask is added 3.12 g. of 4-pyridyl£ormimidoylglycyl-D-phenylglycine. The resulting solution is cooled to -15’C. and treated with 1.08 g. of ethyl chloroformate. This reaction mixture is allowed to stir in the cold for 15 min.
6-Aminopenicillanic acid (2.25 g.) is slurried in 20 ml, of dimethylformamide and treated with 1.08 g. of chlorotrimethylsilane. To the resulting solution is added 1.01 g. of triethylamine, resulting in a precipitate of triethylamine hydrochloride. The mixture is cooled to ~104C. and added to
· the solution of the mixed anhydride. The resulting reaction is further cooled to -25*C. and allowed to stir for one hour. The red solution is allowed to warm to room temperature over a 2 hr. period.
Water (20 ml.) is.added to the reaction mixture and the volume concentrated in vacuo to 1/3 to 1/2, and the residual solution treated with 300 ml of methanol. The diluted solution is filtered and the filtrate allowed to stir overnight (21 hrs.). The crystallized 6-[D-2-pheny1-2-(4-pyridylformimidoylaminoacetamido)acetarnido]penicillanic acid is filtered and dried, 2.24 g.
It is identical with the product from Example 1 in all respects. '
In a manner similar to Example 18, 4-pyridylformimidoylglycyl-D2fi| phenylglycine ethoxyformic anhydride can be replaced by the corresponding methoxyformic, .i-propoxyformic and pivalic anhydrides with comparable results.
n<>
7 A
EXAMPLE 19
To a slurry of 3.12 g, Of 4-pyridylfotmimidoylglycyl-D-phenvlglycine in 40 ml. of. dimethylformamide cooled to -20°C. is added 1.0 g. of N-methylmorpholine followed by 1.2 g. of thionyl chloride. The resulting clear solu5| tion is stirred for 45 min. at -15 to -20°C., and is subsequently treated wich 2.16 g. of 6-aminopenicillanic acid in 20 ml. of water, 10 ml. of dimethylformamide at pH. 7.8. After allowing the reaction mixture to stir for 10 min. at -10°C., ic is allowed to warm to room temperature. High-pressureliquid-chromatography of the solution indicates a yield of 335 mg. of 6-(D-210· pheny1-2-(4-pyridylfotmimidoylaminoacetaraido)acetamido]penicillanic acid (6.52 yield).
EXAMPLE 20.
The procedure of Example 19 is repeated for the preparation of 4pyvidylformimidoylglycyl-D-phenylglycyl chloride. The 6-aminopenicillanic
|. acid is replaced by the addition of the indicated 6-aminopenicillanic acid derivative, and the reaction is conducted under che conditions of the indicated example to provide the desired product 6-[D-2-phenyl-2-(4-pyridylforraimidoylaminoacetamido)acetamido]penicillanic acid.
ΰ
ZO?a
'
,,
3q,
h28v_/V CH3 tiJS 0 co,z Reaction Conditions z Example # (CH3O)2P- 3 (n-C3H7)2P- 3 (c6h5)2p- 3 3' ,5'-(t-C4Hg)2-4-HOC6H2CH2- 5B c6h5c°ch2- 7 ch3coch2- 7 ncch2- 7 CH3O2CCH,- 7 CH3CH2COCH2- 7 (CH3)2CHCOCH2- 7 CH3(CH2)2OzCCH2- 7 CgHgCH-N- 9 CH3CH’N- 9 C2H5CH»N- 9 n-C3H7CH»N- 9 (n-C4Hg)3Sn- 11 (CH3)3Sh- 11 (C2H5)3Sn- 11 (l-C4H9)3Sh- 11 (s-C4H9)3Sh- 11 (n-C3H7)3Sn- 11 £-CH30C6H4CH2- 13 (CH3)3C- 13 £-CH3OC6H4C(CH3)2- 13£-o2ng6h4ch2- 13 (c6h5)2ch- 13£-O2NC6H4CH(CH3)- 13 CC13SH2- 15 ICH2CH2“ 15 Br3CCH2- 15 Br2CHCH2- IS
a j
7
EXAMPLE 21
To a suspension of 3.12 g. of 4-pyridylformimidoylglycyl-D-phenylglycine in 40 ml. of l-methyl-2-pyrrolidone cooled to -20°C. is added 1.0 g. of N-methylmorpholine followed by 1.2 g. of thionyl chloride. . The resulting bi clear solution is allowed to.stir at -15 to -20’C. for 45 min. .
6-Aminopenicillanic acid (2.25 g.) is slurried in 20 ml. of 1-methyli2-pyrrolidone and created with 1.08 g. of chloro trimethylsilane. To the resulting solution is· added 1.01 g. of triethylamine, resulting in a precipitate of trie thy latnine hydrochloride. The mixture is cooled to -10°C. and
[l added, to the solution of the 4-pyridylformimidoylglycyl-O-phenylglycyl chloride. The resulting reaction-mixture is further cooled to -25°C. and allowed to stir for one hour, and then allowed to warm to room temperature. j
Water (20 ml.) is added and the volume of the hydrolyzed mixture reduced in vacuo to 1/2. The residual solution is treated with 300 ml. of
15j| methanol. The precipitated 6-[D-2-phenyl-2-(4-pyridylformimidoylaminoacetamido)acetamido]penlcillanic acid, which is filtered and dried, is identical to the product of Example 1.
EXAMPLE 22
A solution of 3.12 g. of 4-pyridylformimidoylglycyl-D-phenylglycine in 30 ml. of dimethylformamide is cooled to -15°C. and treated with 1.18 g. of ethyl chloroformate. After stirring for 15 min. 1.15 g. of N-hydroxy5' succinimide is added and the solution allowed to warm to room temperature.
I
The reaction mixture is diluted with 60 ml. of diethyl ether, and the Nhydroxysuccinimide ester hydrochloride allowed to crystallize. The interme- ι diate product 'is filtered and washed with cold ether.
A solution of 3.5 g. of ester hydrochloride in 40 ml. of dimethyl10 formamide is treated with 2.16 g. of 6-aminopenicillanic acid, and the resulting slurry treated with 850 mg. of pyridine. The reaction mixture is stirred at -10°C. for 30 min. and then allowed to stir at room temperature forj 2 hrs. The reaction is diluted with 200 ml. of methanol and the pH adjusted to 5.5 with dilute hydrochloric acid. The resulting precipitate, which is
If filtered and dried in vacuo, is identical with the product of Example 1.
¢3072
EXAMPLE 23
A solution of 3.12 g. of 4-pyridylformimidoylglycyl-D-phenylglycine in 40 ml. of dimethylformamide is treated with 1.35 g. of 1-hydroxybenzotriazole, followed by 2.10 g. of dicyclohexylcarbodiimide. The solution is cooled
' to 0°C. and 2.16 g. of 6-aminopenicillanic acid and 1.1 g. of triethylamine in 25 ml. of dimethylformamide is added. The reaction mixture is allowed to stir for one hour in the cold and then allowed to warm to room temperature.
I
After stirring ac room temperature fot one hour, the mixture is hydrolyzed with 50 ml. of water. The precipitated urea is filtered and the filtrate lcji diluted with 200 ml., of methanol. The solution is adjusted to pH 5.5 with ! dilute hydrochloric acid, and the precipitate which forms on standing is filtered and dried in vacuo. The product is identical to that formed in Example
- 40 EXAMPLE 24
To 3.12 g. of 4-pyridylformimidoylglycyl-D-phenylglycine in 30 al. of l-methyl-2-pyrrolidone cooled to -15’C. is added 1.18 g. of ethyl chloroformate. After stirring in the cold for 15 min., 1.8 g. of N-hydroxyphthal51 imide is added and the solution allowed to warm to room temperature. Diethyl ether (60 ml.) is added, and the precipitated ester hydrochloride intermediate is filtered and dried.
A solution of the ester hydrochloride (4.57 g.) in 45 ml. of l-methy]} 2-pyrrolidone cooled to O’C. is treated with 2.16 g. of 6-aminopenicillanic acid and 850 mg. of pyridine. The mixture is stirred in the cold for one hour and then gradually allowed to warm to room temperature. After 30 min. the pH is adjusted to 5.5 and the solution diluted with 225 ml. of methanol. The product, which is filtered and dried in vacuo, is the same as that isolated in Example 1.
EXAMPLE 25
The 4-pyridylformimidoylglycyl-D-phenylglycine derivative employed and isolated in Examples 22, 23 and 24 are prepared and coupled with the following 6-am3.nopenicillanic acid derivatives, employing the reaction conditions of the indicated example to give the product of Example 1:
O'? 3
icj
I·
2θ!
!
(ch3o)2p(n-C3H7)2PCc6h5)2p3 ’, 5 ’ - (t-C^Hg) 2-4' -HOC6H2CH2·
CgH-COCH,CH COCHZncch2CH302CCH2CH3CH2COCH,(CH3),CHCOCH,CH3(CH2)2Q2CCH2. CgHjCH’N,CH3CH’NC,HSCH=Nn-C3H7CH=N= (n-C^HgljSh(CH3)3SnCc2h5)3s„3SnC^—C^Hg)3Sn(n-^H^JjSa£-CH3OC6H4CH2(ch3)3c£-ch3oc6h4c(ch3)2£-O2NC6H4CH2<c6h5)2ch2-02nc6r4ch(ch3)CCLjCHjich2ch2Br3CCH2Br2CHCH2Reactlon Conditions Example !t
SB
IS
IS
- 42 EXAMPLE 26
To a slurry of 2.25 g. of 6-aminopenicillanic acid in 20 ml..of dimethylformamide is added. 1.08 g. of chloro trimethylsilane followed by 1.01 g. of triethyl amine. The reaction mixture is cooled to -10’C. and 3.5 g. of 45 pyridylformimidoylglycyl-D-phenylglycine N-hydroxysuccinimide ester hydrochloride, prepared by the procedure of Example 22, in 35 ml. of dimethylformamide is added. The resulting reaction mixture is further cooled to -20°C. and allowed co stir for 2 hrs., and Is then stirred at room temperature for one hour.
Water (20 ml.) is added to the reaction mixture and to volume reduced under reduced pressure to 1/3. The residual solution is treated with 1 300 ml. of methanol, and the precipitated product filtered and dried. The 6- (D- 2-pheny 1-2- (4-pyridylf ormimidoylam.inoace tamido ] acetamido) penicillanic is identical to that of Example 1.
In a similar manner, the 1-hydroxybenzotriazole and N-hydroxyphthalimide esters of 4-pyrldylformimidoylglycyL-D-phenyIg.t.ycine, prepared in Examples 23 and 24, respectively, can be substituted for the N-hydroxysuccinimide of the present example with similar results.
I
- 43 EXAMPLE 27
To a cooled (0°C.) solution of 5.04 g. of tri-n-butyltin e-aminopenicillinate and 3.12 g._ of 4-pyridylformimidoylglycyl-D-p.henylglycine in 50 ml. of dimethylformamide is added 2.10 g. of dicyclohexylcarbodiimide. The mixture is stirred for one hour in the cold, and then allowed to warm to room temperature, where it is Stirred for an additional 2 hrs. The resulting, reaction mixture is then treated with 1.6 g. of potassium thiophenoxide and allowed! to stir for one hour longer. The mixture is diluted with 20 ml. of water and the pH adjusted to 7.5. The insoluble urea is filtered'and the filtrate ad10 justed to pH 5.5 and diluted with 200 ml. of methanol. The product, which is filtered and dried, is identical with that obtained in Example 1.
Similar results are obtained when M,N-bis(morpholinoethyl)carbodiimide is used in place of dicyclohexylcarbodiimide in the procedure of Example 27,
- 44 -·»
EXAMPLE 28
Starting with 4-pyridylformimidoylglycyl-D-phenylglycine and either dicyclohexylcarbodiimide or N,N-bis(morpholinoethyl)carbodiimide, the procedure of Example 27 is repeated employing, in place of tri-n-butyltin 6-aminopeni5 cillinate, the indicated 6-aminopenicillanic acid derivative and using the work-up procedure of the indicated example, to provide the desired product,
6-[D-2-phenyl-2-(4-pyridylformimidoylaminoacetamido)acetamidoJpenicillanic acid.
Reaction Conditions Z Example # • (ch3o)2p- 3 (n-C3H7)2P- 3 5 ^C6H5^2F_ 3 3',5'-(t-C4Hg)2-4-H0C5H2CH2- 5b CgHgCOCHj- 7 . ch3cogh2- 7 ncch2- 7 10 CH3O2CCH2- 7 GH3CH2COCH2- 7 (CH3)2CHC0CH2- 7 CH3(CH2)2O2CCH2- 7 CgHgCH=N- 9 15; CH3CH=N- 9 C2H5CH»N- 9 n-C3H7CH»N- 9 Cn.“C4Hg)3Sn- - 11 3)3Sh- 11 27 (C2H5)3Sn- 11 (i-C4Hg)3Sn- 11 (s-C4Hg)3Sn- 11 (2-C3H7)3Sn- 11 2-ch3oc6h4ch2- 13 2^ (ch3)3c- 13 ·; £-ch3oc6h4ccch3)2- 13£-o2nc5h4ch2- 13 (CgH5)2CH- 13 £-O2NCgH4CH(CH3)- 13 3(if cci3ch2- 15 . ich2ch2- 15 Br3CCH2- 15 Br2CHCH2- 15 H- 1
EXAMPLE 29
To a slurry of 2.25 g. of 6-aminopenicillanic acid in 20 ml. of dimethylformamide is added 1.08 g. of chloro trimethylsilane followed by 1.01 g. of triethyl amine. The reaction mixture is cooled to -10°C. and 3.12 g. of 45 pyridylformimidoyiglycyl-D-phenylglycine and 2-1 g. of dicyclohexylcarbodiimide: in 35 ml. of dimethylformamide is added. The ragulting reaction mixture is further cooled to -20°C. and allowed to stir for 2 hrs., and is then stirred at room temperature for one hour.
Water (20 ml.) is added to the reaction mixture, the precipitated dicyclohexylurea is filtered and the volume reduced under reduced pressure co 1/3. The residual solution is treated with 300 al. of methanol, and the precipitated product filtered and dried. The 6-[D-2-phenyl-2-[4-pyridyl£ormirni~ doylaminoacetamido]aeetamido)penicillanic is identical to chat of Example 1.
In a similar manner, N,N-bis(morpholinoethyl)carbodiimide c«n be substituted for the dicyclohexylcarbodiimide of the present example wich similar results·.
·· 47 a a
3
EXAMPLE 30
A solution of 3.12 g. of 4-pyridylformimidoylglycyl-D-phenylglycine in 40 ml. of dimethylformamide is treated with 1.39 g. of p^nitrophenol, followed by 2.10 g. of dicyclohexylcarbodiimide. The solution is cooled to 0°C.
and 2.16 g. of 6-aminopenicillanic acid and 1.1 g. of triethylamine in 25 ml. of dimethylformamide is added. The reaction mixture is allowed to stir for one hour in the cold and then allowed to warm to room temperature. After stirring at room temperature for one hour, the precipitated dicyclohexylurea is filtered and the mixture is diluted with 200 ml. of methanol. The solution
' is adjusted to pH 5.5 with dilute hydrochloric acid, and the precipitate which forms on standing is filtered and dried in vacuo. The product is identical to that formed in Example 1.
EXAMPLE 31
That portion of the procedure of Example 30 for the preparation of the 4-pyridylformimidoylglycyl-D-phenylglycine ester is repeated employing che appropriate phenol or thiophenol indicated. This ester is coupled with the requisite 6-amiaopenicillanic acid derivative under the acylation and work-up conditions of the indicated example to give the desired product, 6-[D-2phenyl-2-iC4-pyridylformimidoylaminoacetamido)acetamido]penicillanic acid.
- 48 H,N
S
ch3
I CH3 c-o-z
II 0
HN
I /NHCH,CONHCHCOX I
iO
Z X Reaction Conditions Example # (ch3o)2p- c6h5o- 3 (ch30)2p- 2-C5H4NS- 3 (n-C3H7)2P- 4-ClC6H40- 3 (c6h5)2p- 4-ClC6H4S- 3 (c6hs)2p- 4-N02C6H4S- 3 3',5'-(t-C4Hg)2- 4-H0C6H2CH2- 4-ClC6H4O- 5B ‘ C,HcCOCH_6 5 2 w- 1 CgHgCOCH,- 4-NO2C6H4S- 7 ch3coch2- 4-N02C6H4S- 7 CH3C0CH2- 2-CcH,NS5 4 7 CH3C0CH2- 4-NO2c6H4°- 7 ncch2- 4-ΝΟ2Ο6Η4θ- 7 CH302CCHz“ c6h5s- 7 ch3o2cch2- 2-CsH4NS“ 7 ch,ch,coch7- 4-ClC^O- 7 ch,ch7coch7- 4-ClC6H4S- 7 (ch,)?chcoch,- 4-ClC,H.S6 4 7 (ch,),chcoch7- 4-N02C6H40- 7 CH3(CH2)2O2CCH2- c6h5o- 7 CH3(CH2)2O2CCH2-W- 7 C,H-CHeN6 5 c6h5s- . 9 C2H5CH«N- 4-ClC6H4S- 9 C,HsCH»N- 4-Ν0206ΗλΟ- 9
(Continued. . . )
07 3 (Continued. . .)
Z X Reaction Conditions Example ;f 4-ClCgH4O- 11 5 (CH3)gSn- . 4-ClCgH4O- 11 . (i-C4H9)3Sk- CgHss- 11 - (n-C3Hy)3Sn- CgH5S- 11 (n-C3H7)3Sn- CgHgO- 11 £-CH3OCgH4CH2- 4-ClCgH4S- 13 10 £-CH3OCgH4CH2- 2-C5H4NS- 13 (ch3)3c- 4-NO2CgH4O- 13 £-CH30CgH4C(CH3)2- 4-ClCgH4S- 13£-no2c6h4ch2- 4-N02CgH40- 13 · (CgH5)2CH-C5H5°- 13 15' £-NO2CgH4CH(CH3)- CgH5O- 13 cci3ch2- 4-ClC,H.O6 4 15 cci3ch2- 4-ClCgR4S- 15 CCIjCHj- 4-N°2CgH4S- 15 xch2ch2- CgHgO- 15 20 Br3CCH2- 2-C5H4NS- 15 Br2CHCH2- 4-ClCgH40- 15
- 50 EXAMPLE 32
To a slurry of 4.5 g. of 6-aminopenicillanic acid in 40 ml. of dimethylformamide is added 1.28 g. of dichloro dimethylsilane followed by 2.02 g of triethyl amine. The reaction mixture is cooled to -10°C. and 7.0 g. of 45 pyridylformimidoylglycyl-D-phenylglycine N-hydroxysuccinimide ester hydrochloride, prepared by the procedure of Example 22, in 70 ml. of dimethylformamide is added. The resulting reaction mixture is further cooled to -20°C. and allowed to stir for 2 hrs., and is then stirred at room temperature for one hour.
Hater (40 ml.) is added to the reaction mixture and to volume reduced under reduced pressure to 1/3. The residual solution is treated with 600 ml. of methanol, and the precipitated product filtered and dried. The 6-[D-2-pheny1-2-[4-pyridyIformimidoylaminoacetamido]acetamido)penicillanic is identical to that of Example 1.
- 51 EXAMPLE 33
A suspension of 4.2 g. of 6-aminopenicillanic acid saccharimide hydrochloride in 50 mi. of dimethylformamide is treated with 1.01 g, of triethylaminA and the solution cooled to -5°C. To this solution is added 4-pyridylformimi3’ doylglycyl-D-phenylglycine ethoxyformic anhydride as prepared in Example 5A over a period of 5 minutes. The reaction mixture is allowed to stir In the cold for 30 minutes, and is then treated with S40 mg. of sodium bicarbonate in 10 ml. of water. After stirring at room temperature, the reaction pH is adjusted to 5.5 with’dilute hydrochloric acid. The volume .of the reaction is
If. concentrated in vacuo to about 60 ml. and 200 ml. of methanol is added. The precipitate which forms on standing is filtered and dried to give 6-[D-2-phenyl!2-(4-pyridylformimidoylaminoaceeamido)acetamido]penicillanic acid, identical to that from Example 1.
EXAMPLE 34 ‘ΐ δ ο 7
The procedure of Example 33 is repeated, substituting for 4-pyridylformimidoylglycyl-D-phenylglycine ethoxyformic anhydride che following mixed anhydride prepared from Examples 2 and 4, to give the desired product, 6-[D-25 phenyl-2-(4-pyridylformimidoylarninoacecamido)acetamido]penicillanic acid:
4-pyridylformimidoylglycyl-D-phenylglycine pivalic anhydride;
4-pyridylformimidoylglyeyl-D-phenylglycine methoxyformic anhydride;
4-pyridylformimidoylglycyl-D-phenylglycine .i-propoxyformic anhydride;
and
4-pyridylformimidoylglycyl-D-phenylglycine n-butoxyformic anhydride.
- 53 4»
Qi'
EXAMPLE 35
To a slurry of 3.12 g. of 4-pyridylformimidoylglycyl-D-phenyLglycine in 40 ml. of dimethylformamide cooled to -20°C. is added 1.0 g. of N-methylmorpholine followed by 1.2 g. of thionyl chloride. The resulting solution is
' allowed to stir for 45 minutes at -15 to -20°C., and is then allowed to warm to -5°C.
A suspension of 4.2 g. of 6-aminopenicillanic acid saccharimide hydrochloride in 50 ml. of dimethylformamide is treated with 1.01 g. of triethylamine, cooled to -5°C. and added over a 5 minute period to the above acid.
1Q.; chloride. The resulting reaction mixture is allowed to stir at -5°C. for 30 minutes. Sodium bicarbonate (840 mg.) in 10 ml. of water is added to the reaction mixture and the resulting solution allowed to stir at room temperature for 3 hours. The pH is adjusted to 5.5 by the addition of dilute hydrochloric acid and the vdlume of the solution concentrated under reduced pres15i sure to about 60 ml. Methanol (200 ml.) is added and the solution allowed to stand at room temperature until crystallization ceases. The product, which isi filtered and dried, is identical with the product of Example 1.
- 54 «807^
EXAMPLE 36
A solution of 3.5 g. of 4-pyridylformimidoylglycyl-D-phenylglycine NI hydroxysuccinimide ester hydrochloride, prepared by the procedure of Example 22, in 40 ml. of dimethylformamide is treated with 4.2 g. of 6-aminopenicillanic acid saccharimide hydrochloride, cooled to -5°C. and the resulting slurry treated with 1.7 g. of pyridine. Stirring in the cold is continued for 45 minutes, followed by the addition of 840 mg. of sodium bicarbonate in 10 ml. of water. After stirring at room temperature for 3 hours, the pH is adjusted to 5.5 with dilute hydrohcloric acid and 200 ml. of methanol is added. On standing, the product crystallizes and is subsequently filtered and dried.
The product, 6-[D-2-phenyl-2-(4-pyridylformimidoylaminoacetamido)acetamido]penicillanic aeid ia identical with that formed in Example 1.
Example 37
A solution of 3.12 g. of 4-pyridyl£oraitaidoylglycyl-D-phenylglycine in 40 ml. of dimethylformamide is treated with 1.35 g. of 1-hydroxybenzotriazole, followed by 2.10 g. of dicyclohexylcarbodiimide. The solution is cooled to -5’C. and 4.2 g. of 6-aminopenicillanic acid saccharimide hydrochloride and) 1.1 g. of triethylamine in 25 ml. of dimethylformamide is added. The reaction) mixture is allowed to stir for one hour in the cold and then allowed to warm
201' to room temperature. Sodium bicarbonate (840 mg.) in 30 ml, of water is added!
’ i and the reaction mixture allowed to stir for 3 hours. The precipitated dicyclohexylurea Is filtered and the filtrate adjusted to a pH of 5.5 Follow-1 ing concentration in vacuo to about 50 ml., 200 ml. of methanol is added, and the solution allowed to stand at room temperature. The product, after fil25 tration and drying, proved to be identical to the 6-[D-2-phenyl-2-(4-pyridylformimidoylaminoacetamido)acetamido]penicillanic acid of Example 1.
EXAMPLE 38
A solution of 4.57 g. of 4-pyridyIformimidoylglycyl-D-phenylglycine N-hydroxyphthalimide ester hydrochloride, prepared according to the procedure of Example 24, in 45 ml. of l-methyl-2-pyrrolidone cooled to -5°C. is created with 4.2 g. of 4-aminopenicillanic acid saccharimide hydrochloride followed by 850 mg. of pyridine.. After stirring at -5°C. for 45 minutes, the mixture is allowed to warm to room temperature. Sodium bicarbonate (840 mg.) in 10 ml. of water is added and the reaction mixture allowed to stir for an additional 3 hours, the pH is adjusted to 5.5 and 200 ml. of methanol Is added, the lol precipitate which forms, when filtered and dried, is identical to the 6—[D—2— phenyl-2-(4-pyridyIformimidoylaminoacetamido)acetamido]penicillanic of Example 1.
EXAMPLE 39
To a cooled (-50C.) solution of 4.2 g. of 6-aminopenicillanic acid ΐγ saccharimide hydrochloride, 3.12 g. of 4-pyridylformimidoylglycyl-D-phenylglycine and 1.01 g. of triethylamine in 50 ml. of dimethylformamide is added 2.10 g. of dicyclohexylcarbodiimide, and the reaction mixture allowed to stir in the cold for 45 minutes, the mixture i3 allowed to warm to room temperature followed hy the addition of 840 mg. of sodium bicarbonate in 20 ul. of
2(j water. The precipitated dicycloheXyluren is filtered and the filtrate concentrated to about 45 ml. The pH is adjusted to 5.5 and 200 ml. of methanol is added. The product, which is filtered and dried, is identical to the 6[D-2-phenyl-2(4-pyridylformimidoylaminoacetamido)acetamido]penicillanic acid of Example. 1»
- 56 EXAMPLE 40
A solution of 3.12 g. of 4-pyridylformimidoylglycyl-D-phenylglycine in 40 ml. of dimethylformamide is treated with 1.39 g. of £-nitrophenol, followed by 2.10 g. of dicyclohexylcarbodiimide. The solution is cooled to -5°C.
' and 4.2 g. of 6-aminopenicillanic acid saccharimide hydrochloride and 1.1 g. of triethylamine in 25 ml. of dimethylformamide is added. The reaction mixture is allowed to stir for one hour in the cold and then allowed to warm to room temperature. After stirring at room temperature for 3 hours with 840 mg. of sodium bicaronate in 10 ml. of water, the precipitated dicyclohexylurea is filtered and the mixture is diluted with 200 ml. of methanol. The solution is adjusted to pH 5.5 with dilute hydrochloric acid and the precipitate which forms on standing is filtered and dried in vacuo. The product is identical to that formed in Example 1.
EXAMPLE 41
That portion of the procedure of Example 40 for the preparation of the 4-pytidylformimidoylglycyl-D-phenylglycine ester is repeated employing the appropriate phenol or thiophenol indicated. This ester is coupled with the requisite 6-aminopenicillanic acid saccharimide derivative under the acylation andworx-up conditions indicated to give the desired product, 6-[D-2-phenyl2-(4-pyridyIformimidoylaminoacetamido)acetamidoJpenicillanic acid.
'1
4-ClCgH^Oc6h5oC6H5S4-C1C.H.SO 4
2-CjH^NS-
Claims (35)
1. A process for the preparation of a compound of the formula: which comprises contacting a compound of the formula: wherein X is chloro, phenoxy, 4-chlorophenoxy, 4-nitrophenoxy phenylthio, 4-chlorophenylthio, 4-nitrophenylthio, 2-pyridylthio, N-phthalimidoxy, N-succinimidoxy, 1-benzotriazoloxy, -0-C(=NR')NHR wherein R^ and R are eaeh eyclohexyl or 10 N-morpholinoethyl, or R-^-0- wherein R is selected from alkoxy having from one to four carbon atoms and t-butyl, with a 6-aminopenicillanic acid of the formula: wherein Z is hydrogen or a blocking moiety, in a reaction15 inert solvent at a pH of 3.5 - 8 and reaction temperature of 0 to -15°c, followed if necessary by removal of the blocking moiety J5. - 59 5
2. A process according to claim 1, wherein the blocking moiety Z is selected from ' / a) -P wherein R^ and R 2 are eac b selected from alkyl having one to three carbon atoms, alkoxy having one to three carbon atoms and phenyl; b) 3,5-di-t-butyl-4-hydroxybenzyl; θ » o) -CH 2 ~Y wherein ϊ is selected from -C-Rg wherein R^ is selected from phenyl and alkyl having one to three carbon atoms, -CN and carboalkoxy having two to four carbon atoms; d) -N=CH-R^ wherein R^ is selected from phenyl and alkyl having one to three carbon atoms; e) -Sh(R 5 ) 3 wherein R g is alkyl having one to four carbon atoms; f) -CR,R_R„ wherein R, and R_ are each selected from 6 7 8 6 7 hydrogen, phenyl and methyl and Rg is selected from phenyl, 4-methoxyphenyl, 4-nitrophenyl and methyl, provided that when R g and Ry are each methyl, Rg is also methyl; 20 g) -CH 2 CRgR^ 0 R 13 wherein R g is selected from bromo, chloro and iodo and R-^θ and R 11 are each selected from hydrogen, bromo, chloro and iodo; and h} -Si(CH 3 ) 2 R^ 2 wherein R 32 is selected from methyl and 6- aminopenicillanoyloxy. 25
3. The process of olaim 1 wherein R is ethoxy, Z is hydrogen, the reaction-inert solvent is l-methyl-2-pyrrolidone and the reaction temperature is -1O°C. 60 42072
4. The process of claim 2 wherein R is ethoxy, Z is the blocking Z R 1 moietv -P wherein R. and R, are each methoxv, the reaction-inert solvent ' Xr 2 is dimethylformamide and the reaction temperature is O’C.
5. The process of claim 4 wherein the blocking moiety Z is removed by aqueous hydrolysis.
6. The process of claim 2 wherein R is ethoxy, Z is the blocking moiety 3,5-di-t i -butyl-4-hydroxybenzyl, the reaction-inert solvent is dimethylformamide and the reaction temperature is -10’C.
7. The process of claim 6 wherein the blocking moiety Z is removed by aqueous hydrolysis at a pH of about 8.
8. The process of claim 2 wherein R is ethoxy, Z is the blocking II noiety -CH^-Y wherein t is -C-Rg wherein R^ is phenyl, the reaction-inert solvent is dimethylformamide and the reaction temperature is -10’C.. *
9. The process of claim 8 wherein the blocking moiety Z is removed with potassium thiophenoxide.
10. The process oE claim 2 wherein R is ethoxy, Z is the blocking moiety -N-CHR^ wherein R^ is phenyl, the reaction-inert solvent is dimethylformamide and the reaction temperature is O’C.
11. The process of claim 10 wherein the blocking moiety Z is removed with sodium iodide.
12. The process of claim 2 wherein R is ethoxy, Z is the blocking moiety -Sn(Rg) 3 wherein Rg is n-butyl, the reaction-inert solvent is dimethylformamide and the reaction temperature is -5’C.
13. The process of claim 12 wherein the blocking moiety Z is removed with potassium thiophenoxide.
14. The process of claim 2 wherein R is ethoxy, Z is the blocking moiety -CRgR^Rg wherein Rg and R? are each hydrogen and Rg is £-methoxyphenyl, the reaction-inert solvent is dimethylformamide and the reaction temperature is -10°C.
15. The process of claim 14 wherein the blocking moiety Z is removed' by acid hydrolysis with hydrofluoric acid.
16. The process of claim 14 wherein the blocking moiety Z is removed by catalytic hydrogenation.
17. The process of claim 2 wherein R is ethoxy, Z is the blocking inert solvent is dimethylformamide and the reaction temperature is -5°C.
13. The process of claim 17 wherein the blocking moiety Z is removed by electrolytic reduction.
19. The process of claim 2 wherein R is ethoxy, Z is the blocking 15 moiety -SifCHg/jR^ wherein R^ is CH^, the teaction-inert solvent is dimethylformamide and the. reaction temperature is -10°C.
20. The process of claim 19 wherein the blocking moiety Z is removed by aqueous hydrolysis.
21. A process for the preparation of a compound of the formula: NH co 2 H - 62 which comprises contacting a compound of the formula.' NH 0 C-NHCH.CONHCH-C-X wherein X is chloro, phenoxy, 4-chlorophenoxy, 4-nitrophenoxy, phenylthio, 4chloropheny1thio, 4-nitrophenylthio, 2-pyridylehio, N-phthalimidoxy, N-succiniI II ( II midoxy, 1-benzotriazoloxy, -O-C(”NR )NHR wherein R and R are each cyclohexyl It 5 or N-morpholinoethyl, or R-C-O- wherein R is selected from alkoxy having one to four carbon atoms and t-butyl, with a 6-aminopenicillanic acid of the formula: in a reaction-inert solvent and reaction temperature of -10 to -5°C., followed by aqueous hydrolysis of the saccharimide group at a pH of 88-5' 0 II
22. The process of claim 21 wherein X is R-C-O- wherein R is ethoxy, the reaction-inert solvent is dimethylformamide and the reaction temperature is -5°C. wherein Z is selected from -PR 3 R 2 wherein R^ and R 2 are each selected.? from alkyl having one to three carbon atoms, alkoxy having one to three carbon atoms and phenyl?
3. ,5-di-t-butyl-4-hydroxybenzyl; -GBL-Y wherein Y is selected from -C-R 3 wherein R 3 is selected from phenyl and alkyl having one to three carbon atoms, -CN and carboalkoxy having two to four carbon atoms; -N=CHR 4 wherein R^ is selected from phenyl and alkyl having one to three carbon atoms; -Sn(Rg) 3 wherein Rg is alkyl having one to four carbon atoms? -CRgR^Rg wherein Rg ahd R? are each selected from hydrogen, phenyl and methyl and Rg is selected from methyl, phenyl, 4-methoxyphenyl and 4nitrophenyl, provided that when R g and R? are each methyl, Κθ is also methyl; -CHjCRgR-^R^ wherein R g is selected from bromo, chloro and iodo and R^ Q and R^ are each selected from hydrogen, bromo, chloro and iodo; and Si(CH 3 ) 2 R 12 wherein R.^2 selected from methyl and 6-aminopenioillanoyloxy. - 64 *3073
24. A compound of claim 23, formula I, wherein Z is -PR 1 R 2 wherein R^ and R 2 are each alkoxy having one to three carbon atoms.
25. The compound of claim 24 wherein R^ and R 2 are each methoxy.
26. The compound of claim 23, formula I, wherein Z is 3,5-di-t-butyl-4-hydroxybenzyl. 0 II
27. The compound of claim 23, formula I, wherein Z xs -CHgCRg wherein Rg is phenyl.
28. The compound of claim 23, formula I, wherein Z is -N=CHR 4 wherein R^ is phenyl.
29. The compound of claim 23, formula I, wherein Z is -Sn(Rg)g wherein Rg is n-butyl.
30. A compound of claim 23, formula I, wherein Z is -CR g R 7 Rg wherein Rg and R 7 are each Selected from hydrogen, phenyl and methyl.
31. The compound of claim 30 wherein Rg and R 7 are each hydrogen and R g is phenyl.
32. A compound of claim 23, formula I, wherein Z is -CH^CRgR^QR^^ wherein R lo and R^^ are each selected from hydrogen, bromo, chloro and iodo.
33. The compound of claim 32 wherein Rg, R 10 and R^^ are each chloro.
34. The compound of claim 23, formula I, wherein Z is -Si(CHg)3.
35. The compound of claim 23, formula II.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE1608/79A IE45073B1 (en) | 1976-06-03 | 1977-06-02 | 4-pyridylformimidoylglycyl-d-phenyl-glycine and derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69232376A | 1976-06-03 | 1976-06-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE45072L IE45072L (en) | 1977-12-03 |
IE45072B1 true IE45072B1 (en) | 1982-06-16 |
Family
ID=24780106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1137/77A IE45072B1 (en) | 1976-06-03 | 1977-06-02 | Synthesis of 6-(d-2-phenyl-2-(4-pyridyl-formimidoylaminoacetamido)-acetamido)penicillanic acid |
Country Status (11)
Country | Link |
---|---|
US (1) | US4073780A (en) |
JP (1) | JPS52148094A (en) |
BE (1) | BE855325A (en) |
DE (2) | DE2724551C3 (en) |
DK (1) | DK206577A (en) |
ES (1) | ES458313A1 (en) |
FR (3) | FR2355019A1 (en) |
GB (2) | GB1540346A (en) |
IE (1) | IE45072B1 (en) |
LU (1) | LU77464A1 (en) |
NL (1) | NL7704353A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2758000A1 (en) * | 1977-12-24 | 1979-07-05 | Hoechst Ag | PROCESS FOR PRODUCING PENICILLINES AND CEPHALOSPORINES |
JPS5725973A (en) * | 1980-07-22 | 1982-02-10 | Tokyo Electric Co Ltd | Thermal label printer |
JPH06262950A (en) * | 1993-03-10 | 1994-09-20 | Yamato Sangyo:Kk | Cover device of automobile |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3793451A (en) * | 1970-11-05 | 1974-02-19 | Monsanto Co | Insecticidal pyridylaminidinoureas |
US3950348A (en) * | 1971-12-30 | 1976-04-13 | Merck & Co., Inc. | Process for preparing e-pyridyl-4-methyloxycarbonyllysine |
BE794886A (en) * | 1972-02-22 | 1973-08-02 | Pfizer | 6- (ALPHA- (OMEGA-GUANIDINOALCANOYLAMINO) ACYLAMINO) -PENICILLANIC ACIDS |
GB1418656A (en) * | 1972-08-02 | 1975-12-24 | Pfizer | 6-alpha-amidino-and imidoylaminoalkanoyl-amino-penicillanic acids |
-
1977
- 1977-02-24 US US05/771,773 patent/US4073780A/en not_active Expired - Lifetime
- 1977-04-21 NL NL7704353A patent/NL7704353A/en not_active Application Discontinuation
- 1977-04-29 ES ES458313A patent/ES458313A1/en not_active Expired
- 1977-05-11 DK DK206577A patent/DK206577A/en unknown
- 1977-05-11 JP JP5419177A patent/JPS52148094A/en active Pending
- 1977-05-31 DE DE2724551A patent/DE2724551C3/en not_active Expired
- 1977-05-31 DE DE2759395A patent/DE2759395C2/en not_active Expired
- 1977-06-01 LU LU77464A patent/LU77464A1/xx unknown
- 1977-06-02 IE IE1137/77A patent/IE45072B1/en unknown
- 1977-06-02 GB GB23484/77A patent/GB1540346A/en not_active Expired
- 1977-06-02 GB GB35363/78A patent/GB1540347A/en not_active Expired
- 1977-06-02 BE BE178140A patent/BE855325A/en unknown
- 1977-06-02 FR FR7716900A patent/FR2355019A1/en active Granted
- 1977-10-17 FR FR7731174A patent/FR2367748A1/en active Granted
- 1977-10-17 FR FR7731173A patent/FR2367766A1/en active Granted
Also Published As
Publication number | Publication date |
---|---|
FR2367748B1 (en) | 1981-12-18 |
DK206577A (en) | 1977-12-04 |
US4073780A (en) | 1978-02-14 |
NL7704353A (en) | 1977-12-06 |
DE2759395B1 (en) | 1980-04-10 |
DE2724551A1 (en) | 1977-12-08 |
GB1540347A (en) | 1979-02-07 |
DE2759395C2 (en) | 1980-12-11 |
DE2724551C3 (en) | 1980-06-12 |
DE2724551B2 (en) | 1979-09-27 |
FR2355019B1 (en) | 1982-07-02 |
JPS52148094A (en) | 1977-12-08 |
FR2355019A1 (en) | 1978-01-13 |
IE45072L (en) | 1977-12-03 |
ES458313A1 (en) | 1978-02-16 |
BE855325A (en) | 1977-12-02 |
FR2367766B1 (en) | 1982-07-02 |
GB1540346A (en) | 1979-02-07 |
FR2367748A1 (en) | 1978-05-12 |
LU77464A1 (en) | 1979-01-19 |
FR2367766A1 (en) | 1978-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2008305294B2 (en) | Pyridin-2 -yl-amino-1, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus | |
CA1326017C (en) | Ribofuranuronic acid derivatives | |
US5272151A (en) | Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances | |
EP0503453A2 (en) | New process for the production of cephalosporines and novel intermediates in this process | |
IE45072B1 (en) | Synthesis of 6-(d-2-phenyl-2-(4-pyridyl-formimidoylaminoacetamido)-acetamido)penicillanic acid | |
GB1593060A (en) | Thioxime cephalosporin and penicillin derivatives | |
US4343943A (en) | Cephalosporin analogs | |
CA2454078A1 (en) | Intermediates in cephalosporin production | |
US4336376A (en) | Process for the preparation of 7-(D(-)-alpha-amino-p-hydroxyphenylacetamido)desacetoxycephalosporanic acid | |
JPH069648A (en) | New production of ceftriaxone | |
GB1582217A (en) | Penicillin derivatives medicines containing the same and process for producing the same | |
AU745379B2 (en) | Deprotection and recrystallization processes | |
EP0015773B1 (en) | N-(6-((acylaminoacylamino or aminoacylamino)phenyl) 1,2-dihydro-2-oxonicotinyl)penicillin compounds, processes for their production and compositions containing them | |
US4610822A (en) | Process for preparing 6-[D(-)-α-(4-C1 -C4)-alkyl-2,3-dioxo-1-piperazinocarbonylamino)phenylacetamido]penicillanic acids | |
CA1080697A (en) | 6'-amino-spiro (cycloalkane-1,2-penam)-3'-carboxylic acid derivatives | |
HU197568B (en) | Process for producing crystalline salts of square brackets open 3siz square brackets closed-2-brackets open square brackets open square brackets open 1-/2-amino-4-thiazolyl/-2-square brackets open square brackets open 2,2-dimethyl-4-oxo-1-sulfoxy-3-azetidinyl square brackets closed-amino square brackets closed-2-oxoehtylidene square brackets closed-amino square brackets closed-oxy brackets closed acetic acid and pharmaceuticals comprising same as active ingredient | |
CA1063108A (en) | Azetidinone derivatives and process for preparation thereof | |
US3316273A (en) | Penicillin aldehydes | |
US5578720A (en) | Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof | |
AU605635B2 (en) | Monohydrate and solvates of a new beta-lactam antibiotic | |
KR850000611B1 (en) | Process for preparing 6-(d(-)-alpha-(4-c1 c4 alkyl-2,3-dioxo-1-piperazino-carbonylamino)-phenylacetamido)penicillanic acid | |
CA1296343C (en) | [(2,2,2-trichloroethoxy)methoxy)]amine | |
KR820000693B1 (en) | Process for preparing semi-synthetic 4''-sulfonyl amino-oleandomycin derivatives | |
CA1261838A (en) | ¬2-¬2-(5-dimethylaminomethylfuran-2-ylmethylthio) -ethylamino-5-(2-methoxypyrid-4-ylmethyl) pyrimidim-4-one| | |
US4113942A (en) | 4-(Tetrazol-5-yl)-Δ3 -cephem compounds |